Vi D Precautions  UMM  Fall 2009?
http://www.umm.edu/altmed/articles/vitamin-d-000340.htm 
Because of the potential for side effects and interactions with medications, you should take dietary supplements only under the supervision of a knowledgeable health care provider.
Taking too much vitamin D (more than 1,000 IU daily) can cause a number of side effects including:
    * Excessive thirst
    * Metal taste in mouth
    * Poor appetite
    * Weight loss
    * Bone pain
    * Tiredness
    * Sore eyes
    * Itchy skin
    * Vomiting
    * Diarrhea
    * Constipation
    * A frequent need to urinate
    * Muscle problems
Getting too much sunlight, however, will not provide an excess of vitamin D, nor is one likely to get too much vitamin D from food sources alone. Generally, excess vitamin D is a result of taking supplements in too high a dose.
People with the following conditions should be cautious when considering taking vitamin D supplements:
    * High blood calcium or phosphorus levels
    * Heart problems
    * Kidney disease
Possible Interactions:
If you are currently being treated with any of the following medications, you should not use vitamin D supplements without first talking to your health care provider.
Vitamin D levels may be increased by the following medications:
Estrogen -- Hormone replacement therapy with estrogen appears to increase vitamin D levels in the blood; this may have a beneficial effect on calcium and bone metabolism. In addition, use of vitamin D supplements in conjunction with estrogen replacement therapy (ERT) increases bone mass more than ERT alone. However, this benefit may be lost with the addition of progesterone.
Isoniazid (INH) -- INH, a medication used to treat tuberculosis, may raise blood levels of vitamin D.
Thiazide -- Diuretics in this class (such as hydrochlorothiazide) increase the activity of vitamin D and can lead to inappropriately high calcium levels in the blood.
Vitamin D levels may be decreased, or its absorption may be reduced, by the following medications:
Antacids -- Taking certain antacids for long periods of time may alter the levels, metabolism, and availability of vitamin D.

Calcium Channel Blockers (such as verapamil ) -- These medications, used to treat high blood pressure and heart conditions, may decrease the production of vitamin D by the body.
Cholestyramine -- This cholesterol-lowering medication, known as a bile acid sequestrant, interferes with the absorption of vitamin D (as well as other fat-soluble vitamins).
Phenobarbital, Phenytoin, and Other Anticonvulsant Medications -- These medications may accelerate the body's use of vitamin D.
Mineral Oil -- Mineral oil also interferes with absorption.
In addition, Vitamin D may enhance the effects of doxorubicin, a medicine used to treat a variety of cancers. More research is needed.
Some doctors recommend following calcium levels closely if vitamin D is taken with digoxin, a medication used to treat irregular heart rhythms. This is because vitamin D improves absorption of calcium. Calcium, in turn, can increase the likelihood of a toxic reaction from this medication.
Weight Loss Products -- Orlistat (also known as alli), a medication used for weight loss, and olestra, a substance added to certain food products, are both intended to bind to fat and prevent the absorption of fat and the associated calories. Because of their effects on fat, orlistat and olestra may also prevent the absorption of fat-soluble vitamins such as vitamin D. Given this concern and possibility, the Food and Drug Administration now requires that vitamin D and other fat-soluble vitamins (namely, A, E, and K) be added to food products containing olestra. How well the body absorbs and uses vitamin D from such food products is not clear. In addition, physicians who prescribe orlistat add a multivitamin with fat soluble vitamins to the regimen.
Alternative Names:
Calciferol; Calcitrol; Cholecalciferol; Ergocalciferol
    * Reviewed last on: 11/9/2007
    * Ernest B. Hawkins, MS, BSPharm, RPh, Health Education Resources; and Steven D. Ehrlich, NMD, private practice specializing in complementary and alternative medicine, Phoenix, AZ. Review provided by VeriMed Healthcare Network.
Supporting Research
American Academy of Sciences. Dietary Reference Intakes: Calcium Phosphorus, Magnesium, Vitamin D, and Fluoride. National Academy Press; 2004.
Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007 Sep 10;167(16):1730-7.
Braun J, Sieper J. [Glucocorticoid-induced osteoporosis] Orthopade. 2001;30(7):444-450. German.
Brawley OW, Parnes H. Prostate cancer prevention trials in the USA. Eur J Cancer. 2000;36(10):1312-1315.
Cashman KD. Calcium and vitamin D. Novartis Found Symp. 2007;282:123-38; discussion 138-42, 212-8.
Gallagher JC, Fowler SE, Detter JR, Sherman SS. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrin Metabol. 2001;86(8):3618-3628.
Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review. Cancer Causes Control. 2005 Mar;16(2):83-95.
Grant WB, Garland CF. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer. 2004;48(2):115-123.
Harris SS. Vitamin D in type 1 diabetes prevetion. J Nutr.2005 Feb;135(2):323-325.
Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004 Mar;79(3):362-371.
Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358(9292):1500-1503.
Jänne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med. 2000;342(26):1960-1968.
Kampman E, Slattery ML, Caan B, Potter JD. Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control. 2000:11:459-466.
Kimball SM, Ursell MR, O'connor P, Vieth R. Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr. 2007 Sep;86(3):645-51.
Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the rennin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):387-392.
Mordan-McCombs S, Valrance M, Zinser G, Tenniswood M, Welsh J. Calcium, vitamin D and the vitamin D receptor: impact on prostate and breast cancer in preclinical models. Nutr Rev. 2007 Aug;65(8 Pt 2):S131-3.
National Institutes of Health, Office of Dietary Supplements. Facts About Dietary Supplements: Vitamin D. August 2001. Accessed November 1, 2005.
Nutrients and Nutritional Agents. In: Kastrup EK, Hines Burnham T, Short RM, et al, eds. Drug Facts and Comparisons. St. Louis, Mo: Facts and Comparisons; 2000.
Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001;86(4):1633-1637.

Reichrath J. Will analogs of 1,25-dihydroxyvitamin D(3) (calcitriol) open a new era in cancer therapy? [Review] Onkologie. 2001;24(2):128-133.
Reginster JY. Calcium and vitamin D for osteoporotic fracture risk. Lancet. 2007 Aug 25;370(9588):632-4.
Semba RD, Garrett E, Johnson BA, Guralnik JM, Fried LP. Vitamin D deficiency among older women with and without disability. Amer J Clin Nutr. 2000;72:1529-1534.
Thornquist MD, Kristal AR, Patterson RE, et al. Olestra consumption does not predict serum concentrations of carotenoids and fat-soluble vitamins in free-living humans: early results from the sentinel site of the olestra post-marketing surveillance study. J Nutr. 2000;130(7):1711-1718.
Valmadrid C, Voorhees C, Litt B, Schneyer CR. Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol. 2001;58(9):1369-1374.
Wagner CL, Hulsey TC, Fanning D, Ebeling M, Hollis BW. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med. 2006 Summer;1(2):59-70.
Welsh J. Vitamin D and prevention of breast cancer. Acta Pharmacol Sin. 2007 Sep;28(9):1373-82.
Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet. 2000;355(9204):618-621.
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690-693.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2010 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.